Jin Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jin Zheng has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Daoxia Guo
School of Nursing Suzhou Medical College of Soochow University Suzhou China
4 shared publicationsLulu Sun
Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology Suzhou Medical College of Soochow University Suzhou China
4 shared publicationsMengyao Shi
Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology Suzhou Medical College of Soochow University Suzhou China
4 shared publicationsYiming Jia
Department of Epidemiology , School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology, 199 Renai Road, Industrial Park District Suzhou, Jiangsu Province 215123 , China
4 shared publicationsYunhe Luo
Department of Neurology, Minhang Hospital, Fudan University
4 shared publications- Zhengbao Zhu
Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzhou Medical College of Soochow University, Suzhou, China
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1891162
Early antithrombotic therapy improves 90-day functional outcomes in patients with postinterventional cerebral hyperdensity after mechanical thrombectomy: a retrospective cohort study
Background and purpose: Postinterventional cerebral hyperdensity (PCHD) is a specific type of hyperdensity commonly observed on computed tomography (CT) scans of the head after mechanical thrombectomy (MT). This study aimed to investigate the association between early antithrombotic therapy (EAT) and 90-day functional outcomes in anterior circulation acute ischemic stroke (acAIS) patients with PCHD. Methods: A retrospective cohort study was conducted on 141 consecutive acAIS patients with PCHD after MT. EAT was defined as antithrombotic therapy administered within 24 h post-MT. The primary outcome was a favorable 90-day functional outcome (modified Rankin Scale (mRS) score of 0–2). The secondary outcomes included 90-day mortality, ΔmRS (defined as the mRS score before MT minus the 90-day mRS score), enlargement of cerebral hyperdensity, and persistent hyperdensity on the 24-h follow-up CT graded by the European Cooperative Acute Stroke Study (ECASS III) morphology. Baseline and outcome data were compared between the EAT and non-EAT groups. Univariate and multivariate logistic regression analyses were performed to assess the association between EAT and favorable outcomes. Sensitivity and subgroup analyses were performed to evaluate the robustness and internal consistency of the results. Results: Of the 129 patients with complete 90-day mRS data, 59 (45.7%) received EAT. The EAT group had a higher proportion of favorable outcomes (59.3% vs. 37.1%, p = 0.019). A multivariate logistic regression analysis showed that EAT remained significantly associated with favorable outcomes (Model 1: odds ratio (OR) 2.469, 95% confidence interval (CI) 1.195–5.104, p = 0.015; Model 2: OR 2.72, 95% CI 1.02–7.20, p = 0.045; Model 3: OR 3.68, 95% CI 1.32–10.30, p = 0.013), and the results were consistent after imputation based on discharge data and multiple imputation. Sensitivity and subgroup analyses showed consistent results, with no significant interaction effects observed. Conclusion: EAT is associated with improved 90-day functional outcomes in acAIS patients with PCHD, warranting further investigation in larger prospective studies.
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1891162
Open AccessEarly antithrombotic therapy improves 90-day functional outcomes in patients with postinterventional cerebral hyperdensity after mechanical thrombectomy: a retrospective cohort study
Background and purpose: Postinterventional cerebral hyperdensity (PCHD) is a specific type of hyperdensity commonly observed on computed tomography (CT) scans of the head after mechanical thrombectomy (MT). This study aimed to investigate the association between early antithrombotic therapy (EAT) and 90-day functional outcomes in anterior circulation acute ischemic stroke (acAIS) patients with PCHD. Methods: A retrospective cohort study was conducted on 141 consecutive acAIS patients with PCHD after MT. EAT was defined as antithrombotic therapy administered within 24 h post-MT. The primary outcome was a favorable 90-day functional outcome (modified Rankin Scale (mRS) score of 0–2). The secondary outcomes included 90-day mortality, ΔmRS (defined as the mRS score before MT minus the 90-day mRS score), enlargement of cerebral hyperdensity, and persistent hyperdensity on the 24-h follow-up CT graded by the European Cooperative Acute Stroke Study (ECASS III) morphology. Baseline and outcome data were compared between the EAT and non-EAT groups. Univariate and multivariate logistic regression analyses were performed to assess the association between EAT and favorable outcomes. Sensitivity and subgroup analyses were performed to evaluate the robustness and internal consistency of the results. Results: Of the 129 patients with complete 90-day mRS data, 59 (45.7%) received EAT. The EAT group had a higher proportion of favorable outcomes (59.3% vs. 37.1%, p = 0.019). A multivariate logistic regression analysis showed that EAT remained significantly associated with favorable outcomes (Model 1: odds ratio (OR) 2.469, 95% confidence interval (CI) 1.195–5.104, p = 0.015; Model 2: OR 2.72, 95% CI 1.02–7.20, p = 0.045; Model 3: OR 3.68, 95% CI 1.32–10.30, p = 0.013), and the results were consistent after imputation based on discharge data and multiple imputation. Sensitivity and subgroup analyses showed consistent results, with no significant interaction effects observed. Conclusion: EAT is associated with improved 90-day functional outcomes in acAIS patients with PCHD, warranting further investigation in larger prospective studies.
- 17 September 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9641
Internal Carotid Artery Tortuosity: an Incremental Predictor of Poor Functional Outcome After Mechanical Thrombectomy
Preoperative prognostic prediction for patients undergoing mechanical thrombectomy (MT) remains suboptimal. Several studies have explored the association between internal carotid artery (ICA) tortuosity and post-MT functional outcomes with inconsistent results, and whether ICA tortuosity provides incremental prognostic value beyond conventional preoperative predictors remains unexplored. We retrospectively analyzed 338 consecutive patients receiving MT for isolated middle cerebral artery (MCA) occlusion between January 2019 and December 2024. ICA tortuosity was qualitatively assessed on preprocedural CTA using standard post-processing workstations and classified into four subgroups: non-tortuosity, extracranial ICA-only, cavernous ICA-only, and both-tortuosity. The primary outcome was major disability or death (modified Rankin Scale [mRS] score 4-6) at discharge, and principal secondary outcome was major disability or death at 3 months. Additional secondary outcomes included favorable functional outcome (mRS 0-2), successful reperfusion (final eTICI ≥2b), angiography-to-recanalization time (ART), and hemorrhagic complications. Multivariable logistic regression assessed associations between tortuosity type and outcomes. Incremental predictive value was evaluated using AUC, NRI, and IDI. Mediation analyses were performed to explore potential pathways. The Both-tortuosity group was independently associated with the primary outcome (65.9% vs 30.6%; adjusted OR = 4.384, 95% CI: 1.790-11.193, P = 0.001), and was similarly associated with 3-month major disability or death (adjusted OR = 5.141, 95% CI 1.954-14.077, P = 0.001). Adding ICA tortuosity type to the conventional preoperative model did not significantly improve the AUC (from 0.731 to 0.756, P = 0.109), but yielded significant risk reclassification improvements (NRI 14.1%, P < 0.001; IDI 3.8%, P < 0.001); the NRI remained significant after bootstrap internal validation, and consistent reclassification benefit was observed across four additional conventional models. Mediation analysis revealed ART mediated 29.8% of the overall tortuosity-outcome effect (P = 0.004) and 39.0% of extracranial ICA tortuosity (P = 0.021), while cavernous ICA tortuosity effect was mediated by successful reperfusion (28.7%, P = 0.022). ICA tortuosity type is an independent predictor of poor early functional outcomes after MT for isolated MCA occlusion and provides incremental prognostic value in terms of risk reclassification. Tortuosity at different ICA segments may exert effects through distinct pathways.
- 17 September 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9641
Internal Carotid Artery Tortuosity: an Incremental Predictor of Poor Functional Outcome After Mechanical Thrombectomy
Preoperative prognostic prediction for patients undergoing mechanical thrombectomy (MT) remains suboptimal. Several studies have explored the association between internal carotid artery (ICA) tortuosity and post-MT functional outcomes with inconsistent results, and whether ICA tortuosity provides incremental prognostic value beyond conventional preoperative predictors remains unexplored. We retrospectively analyzed 338 consecutive patients receiving MT for isolated middle cerebral artery (MCA) occlusion between January 2019 and December 2024. ICA tortuosity was qualitatively assessed on preprocedural CTA using standard post-processing workstations and classified into four subgroups: non-tortuosity, extracranial ICA-only, cavernous ICA-only, and both-tortuosity. The primary outcome was major disability or death (modified Rankin Scale [mRS] score 4-6) at discharge, and principal secondary outcome was major disability or death at 3 months. Additional secondary outcomes included favorable functional outcome (mRS 0-2), successful reperfusion (final eTICI ≥2b), angiography-to-recanalization time (ART), and hemorrhagic complications. Multivariable logistic regression assessed associations between tortuosity type and outcomes. Incremental predictive value was evaluated using AUC, NRI, and IDI. Mediation analyses were performed to explore potential pathways. The Both-tortuosity group was independently associated with the primary outcome (65.9% vs 30.6%; adjusted OR = 4.384, 95% CI: 1.790-11.193, P = 0.001), and was similarly associated with 3-month major disability or death (adjusted OR = 5.141, 95% CI 1.954-14.077, P = 0.001). Adding ICA tortuosity type to the conventional preoperative model did not significantly improve the AUC (from 0.731 to 0.756, P = 0.109), but yielded significant risk reclassification improvements (NRI 14.1%, P < 0.001; IDI 3.8%, P < 0.001); the NRI remained significant after bootstrap internal validation, and consistent reclassification benefit was observed across four additional conventional models. Mediation analysis revealed ART mediated 29.8% of the overall tortuosity-outcome effect (P = 0.004) and 39.0% of extracranial ICA tortuosity (P = 0.021), while cavernous ICA tortuosity effect was mediated by successful reperfusion (28.7%, P = 0.022). ICA tortuosity type is an independent predictor of poor early functional outcomes after MT for isolated MCA occlusion and provides incremental prognostic value in terms of risk reclassification. Tortuosity at different ICA segments may exert effects through distinct pathways.
- Open Access
- 1 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (19) , e036527
Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke
Background: As a risk factor of cardiovascular diseases, homocysteine can be effectively lowered by folate. However, the associations of folate and homocysteine levels with the prognosis of ischemic stroke remained unclear. Methods and Results: A total of 3530 patients with ischemic stroke were included. Serum folate and homocysteine levels were measured at admission. The primary outcome was composite of death and major disability (modified Rankin Scale score≥3) at 3 months after stroke onset. Univariate and multivariate logistic regression models were used. The mediation effect of homocysteine was examined. During follow‐up, 1056 participants developed the primary outcome. In the univariate model, participants in the highest quartile of folate had a 29% (95% CI, 0.58–0.87) decreased risk of primary outcome compared with those in the lowest quartile. After multivariate adjustment, the odds ratio associated with the highest quartile of folate was 0.58 (95% CI, 0.46–0.73) for primary outcome. In contrast, participants in the highest quartile of homocysteine had a 52% (95% CI, 1.24–1.98) increased risk of primary outcome compared with those in the lowest quartile. After multivariate adjustment, the odds ratio associated with highest quartile of homocysteine was 1.57 (95% CI, 1.24–1.98) for primary outcome. In addition, 25.5% of the observed associations between folate and primary outcome was mediated through homocysteine ( P =0.012). Conclusions: High folate levels were associated with low risks of death and major disability among Chinese patients with ischemic stroke, and homocysteine partially mediated the observed potential beneficial role of folate.
- 1 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (19) , e036527
Open AccessFolate, Homocysteine, and Adverse Outcomes After Ischemic Stroke
Background: As a risk factor of cardiovascular diseases, homocysteine can be effectively lowered by folate. However, the associations of folate and homocysteine levels with the prognosis of ischemic stroke remained unclear. Methods and Results: A total of 3530 patients with ischemic stroke were included. Serum folate and homocysteine levels were measured at admission. The primary outcome was composite of death and major disability (modified Rankin Scale score≥3) at 3 months after stroke onset. Univariate and multivariate logistic regression models were used. The mediation effect of homocysteine was examined. During follow‐up, 1056 participants developed the primary outcome. In the univariate model, participants in the highest quartile of folate had a 29% (95% CI, 0.58–0.87) decreased risk of primary outcome compared with those in the lowest quartile. After multivariate adjustment, the odds ratio associated with the highest quartile of folate was 0.58 (95% CI, 0.46–0.73) for primary outcome. In contrast, participants in the highest quartile of homocysteine had a 52% (95% CI, 1.24–1.98) increased risk of primary outcome compared with those in the lowest quartile. After multivariate adjustment, the odds ratio associated with highest quartile of homocysteine was 1.57 (95% CI, 1.24–1.98) for primary outcome. In addition, 25.5% of the observed associations between folate and primary outcome was mediated through homocysteine ( P =0.012). Conclusions: High folate levels were associated with low risks of death and major disability among Chinese patients with ischemic stroke, and homocysteine partially mediated the observed potential beneficial role of folate.
- 3 July 2024
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (7)
Associations between brain imaging–derived phenotypes and cognitive functions
We aimed to evaluate the potential causal relationship between brain imaging–derived phenotypes and cognitive functions via Mendelian randomization analyses. Genetic instruments for 470 brain imaging–derived phenotypes were selected from a genome-wide association study based on the UK Biobank (n = 33,224). Statistics for cognitive functions were obtained from the genome-wide association study based on the UK Biobank. We used the inverse variance weighted Mendelian randomization method to investigate the associations between brain imaging–derived phenotypes and cognitive functions, and reverse Mendelian randomization analyses were performed for significant brain imaging–derived phenotypes to examine the reverse causation for the identified associations. We identified three brain imaging–derived phenotypes to be associated with verbal–numerical reasoning, including cortical surface area of the left fusiform gyrus (beta, 0.18 [95% confidence interval, 0.11 to 0.25], P = 4.74 × 10−7), cortical surface area of the right superior temporal gyrus (beta, 0.25 [95% confidence interval, 0.15 to 0.35], P = 6.30 × 10−7), and orientation dispersion in the left superior longitudinal fasciculus (beta, 0.14 [95% confidence interval, 0.09 to 0.20], P = 8.37 × 10−7). The reverse Mendelian randomization analysis indicated that verbal–numerical reasoning had no effect on these three brain imaging–derived phenotypes. This Mendelian randomization study identified cortical surface area of the left fusiform gyrus, cortical surface area of the right superior temporal gyrus, and orientation dispersion in the left superior longitudinal fasciculus as predictors of verbal–numerical reasoning.
- 3 July 2024
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (7)
Associations between brain imaging–derived phenotypes and cognitive functions
We aimed to evaluate the potential causal relationship between brain imaging–derived phenotypes and cognitive functions via Mendelian randomization analyses. Genetic instruments for 470 brain imaging–derived phenotypes were selected from a genome-wide association study based on the UK Biobank (n = 33,224). Statistics for cognitive functions were obtained from the genome-wide association study based on the UK Biobank. We used the inverse variance weighted Mendelian randomization method to investigate the associations between brain imaging–derived phenotypes and cognitive functions, and reverse Mendelian randomization analyses were performed for significant brain imaging–derived phenotypes to examine the reverse causation for the identified associations. We identified three brain imaging–derived phenotypes to be associated with verbal–numerical reasoning, including cortical surface area of the left fusiform gyrus (beta, 0.18 [95% confidence interval, 0.11 to 0.25], P = 4.74 × 10−7), cortical surface area of the right superior temporal gyrus (beta, 0.25 [95% confidence interval, 0.15 to 0.35], P = 6.30 × 10−7), and orientation dispersion in the left superior longitudinal fasciculus (beta, 0.14 [95% confidence interval, 0.09 to 0.20], P = 8.37 × 10−7). The reverse Mendelian randomization analysis indicated that verbal–numerical reasoning had no effect on these three brain imaging–derived phenotypes. This Mendelian randomization study identified cortical surface area of the left fusiform gyrus, cortical surface area of the right superior temporal gyrus, and orientation dispersion in the left superior longitudinal fasciculus as predictors of verbal–numerical reasoning.
- Open Access
- 15 May 2024
- Published by Wiley in Brain and Behavior
- Vol. 14 (5) , e3523
White matter hyperintensity, parent artery steno‐occlusion, and neurological deterioration in anterior circulation single subcortical infarction patients
Background: The evidence for the association between white matter hyperintensity (WMH) severity and neurological deterioration (ND) in patients with single subcortical infarction (SSI) remains unclear and whether the association between them is modified by anterior circulation parent artery steno‐occlusion (PAS) is unknown. Herein, we aimed to prospectively investigate the internal relevance.Methods: In this prospective study, the severity of WMH and PAS were assessed in 288 consecutive patients with anterior circulation SSI arriving at our hospital, a tertiary teaching hospital affiliated with Fudan University, 24 h after onset from January 2017 to December 2018. The multivariable logistic regression model was used to estimate the association between WMH severity and the risk of ND within 7 days after stroke onset as well as the interactive effect between WMH severity and PAS on ND among patients with SSI.Results: PAS modified the association between WMH severity and ND among patients with SSI (pinteraction = .029). After multivariate adjustment, the odds ratios of moderate‐severe WMH associated with ND were 1.61 (95% CI, 0.50–5.19; ptrend = .428) for patients with PAS, and 0.37 (95% CI, 0.14–0.97; ptrend = .043) for those without PAS. Adding WMH severity to conventional risk factors improved risk prediction for ND in patients without PAS (net reclassification improvement: 48.2%, p = .005; integrated discrimination index: 2.5%, p = .004) but not in those with PAS.Conclusion: There was a modified effect of PAS on the association between WMH severity and ND within 7 days after stroke onset among patients with anterior circulation SSI, which deserves more research attention. WMH was negatively associated with ND in anterior circulation SSI patients without PAS.
- 15 May 2024
- Published by Wiley in Brain and Behavior
- Vol. 14 (5) , e3523
Open AccessWhite matter hyperintensity, parent artery steno‐occlusion, and neurological deterioration in anterior circulation single subcortical infarction patients
Background: The evidence for the association between white matter hyperintensity (WMH) severity and neurological deterioration (ND) in patients with single subcortical infarction (SSI) remains unclear and whether the association between them is modified by anterior circulation parent artery steno‐occlusion (PAS) is unknown. Herein, we aimed to prospectively investigate the internal relevance.Methods: In this prospective study, the severity of WMH and PAS were assessed in 288 consecutive patients with anterior circulation SSI arriving at our hospital, a tertiary teaching hospital affiliated with Fudan University, 24 h after onset from January 2017 to December 2018. The multivariable logistic regression model was used to estimate the association between WMH severity and the risk of ND within 7 days after stroke onset as well as the interactive effect between WMH severity and PAS on ND among patients with SSI.Results: PAS modified the association between WMH severity and ND among patients with SSI (pinteraction = .029). After multivariate adjustment, the odds ratios of moderate‐severe WMH associated with ND were 1.61 (95% CI, 0.50–5.19; ptrend = .428) for patients with PAS, and 0.37 (95% CI, 0.14–0.97; ptrend = .043) for those without PAS. Adding WMH severity to conventional risk factors improved risk prediction for ND in patients without PAS (net reclassification improvement: 48.2%, p = .005; integrated discrimination index: 2.5%, p = .004) but not in those with PAS.Conclusion: There was a modified effect of PAS on the association between WMH severity and ND within 7 days after stroke onset among patients with anterior circulation SSI, which deserves more research attention. WMH was negatively associated with ND in anterior circulation SSI patients without PAS.
- 6 January 2024
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (2)
Genetic analyses identify brain imaging-derived phenotypes associated with the risk of intracerebral hemorrhage
Previous observational studies have reported associations between brain imaging-derived phenotypes (IDPs) and intracerebral hemorrhage (ICH), but the causality between them remains uncertain. We aimed to investigate the potential causal relationship between IDPs and ICH by a two-sample Mendelian randomization (MR) study. We selected genetic instruments for 363 IDPs from a genome-wide association study (GWASs) based on the UK Biobank (n = 33,224). Summary-level data on ICH was derived from a European-descent GWAS with 1,545 cases and 1,481 controls. Inverse variance weighted MR method was applied in the main analysis to investigate the associations between IDPs and ICH. Reverse MR analyses were performed for significant IDPs to examine the reverse causation for the identified associations. Among the 363 IDPs, isotropic or free water volume fraction (ISOVF) in the anterior limb of the left internal capsule was identified to be associated with the risk of ICH (OR per 1-SD increase, 4.62 [95% CI, 2.18–9.81], P = 6.63 × 10−5). In addition, the reverse MR analysis indicated that ICH had no effect on ISOVF in the anterior limb of the left internal capsule (beta, 0.010 [95% CI, −0.010-0.030], P = 0.33). MR-Egger regression analysis showed no directional pleiotropy for the association between ISOVF and ICH, and sensitivity analyses with different MR models further confirmed these findings. ISOVF in the anterior limb of the left internal capsule might be a potential causal mediator of ICH, which may provide predictive guidance for the prevention of ICH. Further studies are warranted to replicate our findings and clarify the underlying mechanisms.
- 6 January 2024
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (2)
Genetic analyses identify brain imaging-derived phenotypes associated with the risk of intracerebral hemorrhage
Previous observational studies have reported associations between brain imaging-derived phenotypes (IDPs) and intracerebral hemorrhage (ICH), but the causality between them remains uncertain. We aimed to investigate the potential causal relationship between IDPs and ICH by a two-sample Mendelian randomization (MR) study. We selected genetic instruments for 363 IDPs from a genome-wide association study (GWASs) based on the UK Biobank (n = 33,224). Summary-level data on ICH was derived from a European-descent GWAS with 1,545 cases and 1,481 controls. Inverse variance weighted MR method was applied in the main analysis to investigate the associations between IDPs and ICH. Reverse MR analyses were performed for significant IDPs to examine the reverse causation for the identified associations. Among the 363 IDPs, isotropic or free water volume fraction (ISOVF) in the anterior limb of the left internal capsule was identified to be associated with the risk of ICH (OR per 1-SD increase, 4.62 [95% CI, 2.18–9.81], P = 6.63 × 10−5). In addition, the reverse MR analysis indicated that ICH had no effect on ISOVF in the anterior limb of the left internal capsule (beta, 0.010 [95% CI, −0.010-0.030], P = 0.33). MR-Egger regression analysis showed no directional pleiotropy for the association between ISOVF and ICH, and sensitivity analyses with different MR models further confirmed these findings. ISOVF in the anterior limb of the left internal capsule might be a potential causal mediator of ICH, which may provide predictive guidance for the prevention of ICH. Further studies are warranted to replicate our findings and clarify the underlying mechanisms.
- Open Access
- 15 December 2023
- Published by Springer Nature in BMC Neurology
- Vol. 23 (1) , 1-8
Early antithrombotic therapy in patients with postinterventional cerebral hyperdensity reduces early neurological deterioration after mechanical thrombectomy
Background: Initiation of early antithrombotic therapy after acute ischemic stroke (AIS) is crucial. We aimed to investigate whether early antithrombotic therapy influences early neurological deterioration (END) in AIS patients with postinterventional cerebral hyperdensity (PCHD) immediately after mechanical thrombectomy (MT). Methods: We retrospectively analyzed 108 consecutive anterior circulation AIS patients with PCHD immediately after MT. All patients were divided into END group and non-END group and END was defined as an increase of four points or more on the postinterventional National Institutes of Health Stroke Scale (NIHSS) score within the first 72 h after MT. Early antithrombotic therapy was defined as patients with PCHD who received antithrombotic therapy within 24 h after MT. Statistical analyses were performed to evaluate the association between early antithrombotic therapy and the risk of END. Results: Among 108 patients, 27 (25%) patients developed END. Multivariate regression analysis revealed that early use of antithrombotic therapy (OR = 0.229, 95%CI = 0.083–0.626, P = 0.004) was an independent protector of END and postinterventional low density shadow exceeding 1/3 of the vascular territory (OR = 4.000, 95%CI = 1.157–13.834, P = 0.029) was an independent risk factor for END. Conclusion: Antithrombotic therapy within 24 h after MT maybe associated with the reduced risk of END in anterior circulation AIS patients with PCHD.
- 15 December 2023
- Published by Springer Nature in BMC Neurology
- Vol. 23 (1) , 1-8
Open AccessEarly antithrombotic therapy in patients with postinterventional cerebral hyperdensity reduces early neurological deterioration after mechanical thrombectomy
Background: Initiation of early antithrombotic therapy after acute ischemic stroke (AIS) is crucial. We aimed to investigate whether early antithrombotic therapy influences early neurological deterioration (END) in AIS patients with postinterventional cerebral hyperdensity (PCHD) immediately after mechanical thrombectomy (MT). Methods: We retrospectively analyzed 108 consecutive anterior circulation AIS patients with PCHD immediately after MT. All patients were divided into END group and non-END group and END was defined as an increase of four points or more on the postinterventional National Institutes of Health Stroke Scale (NIHSS) score within the first 72 h after MT. Early antithrombotic therapy was defined as patients with PCHD who received antithrombotic therapy within 24 h after MT. Statistical analyses were performed to evaluate the association between early antithrombotic therapy and the risk of END. Results: Among 108 patients, 27 (25%) patients developed END. Multivariate regression analysis revealed that early use of antithrombotic therapy (OR = 0.229, 95%CI = 0.083–0.626, P = 0.004) was an independent protector of END and postinterventional low density shadow exceeding 1/3 of the vascular territory (OR = 4.000, 95%CI = 1.157–13.834, P = 0.029) was an independent risk factor for END. Conclusion: Antithrombotic therapy within 24 h after MT maybe associated with the reduced risk of END in anterior circulation AIS patients with PCHD.
- Open Access
- 11 April 2023
- Published by Springer Nature in Thrombosis Journal
- Vol. 21 (1) , 1-8
Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study
Background: Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes. Methods: A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes. Results: Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01–1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01–1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02–1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03–1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings. Conclusions: We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke.
- 11 April 2023
- Published by Springer Nature in Thrombosis Journal
- Vol. 21 (1) , 1-8
Open AccessIntercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study
Background: Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes. Methods: A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes. Results: Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01–1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01–1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02–1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03–1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings. Conclusions: We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke.
- Open Access
- 28 July 2022
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-27
Bioinformatics Analysis Revealing the Correlation between NF-κB Signaling Pathway and Immune Infiltration in Gastric Cancer
Although the emerging of immunotherapy conferred a new landscape of gastric cancer (GC) treatment, its response rate was of significant individual differences. Insight into GC immune microenviroment may contribute to breaking the dilemma. To this end, the enrichment score of NF-κB signaling pathway was calculated in each GC sample from The Cancer Genome Atlas (TCGA) via ssGSEA algorithm, and its association with immune infiltration was estimated. Based on NF-κB-related genes, a risk score was established and its involvement in immune infiltration, tumor mutational burden (TMB), and N6-methyladenosine (M6A) modification was analyzed in GC. The results showed that NF-κB signaling pathway promoted the infiltration of immune cells in GC. In addition, GC samples were divided into low- and high-risk groups according to a seven-gene (CARD11, CCL21, GADD45B, LBP, RELB, TRAF1, and VCAM1) risk score. Although the high-risk group displayed high immune infiltration and high expression of M6A regulatory genes, it remains in an immunosuppressive microenviroment and whereby suffers a poorer outcome. Of note, most of hub genes were related to immune infiltration and could serve as an independent prognostic biomarker. Conclusively, our study emphasized the crucial role of NF-κB signaling pathway in GC immune microenviroment and provided several candidate genes that may participate in immune infiltration.
- 28 July 2022
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-27
Open AccessBioinformatics Analysis Revealing the Correlation between NF-κB Signaling Pathway and Immune Infiltration in Gastric Cancer
Although the emerging of immunotherapy conferred a new landscape of gastric cancer (GC) treatment, its response rate was of significant individual differences. Insight into GC immune microenviroment may contribute to breaking the dilemma. To this end, the enrichment score of NF-κB signaling pathway was calculated in each GC sample from The Cancer Genome Atlas (TCGA) via ssGSEA algorithm, and its association with immune infiltration was estimated. Based on NF-κB-related genes, a risk score was established and its involvement in immune infiltration, tumor mutational burden (TMB), and N6-methyladenosine (M6A) modification was analyzed in GC. The results showed that NF-κB signaling pathway promoted the infiltration of immune cells in GC. In addition, GC samples were divided into low- and high-risk groups according to a seven-gene (CARD11, CCL21, GADD45B, LBP, RELB, TRAF1, and VCAM1) risk score. Although the high-risk group displayed high immune infiltration and high expression of M6A regulatory genes, it remains in an immunosuppressive microenviroment and whereby suffers a poorer outcome. Of note, most of hub genes were related to immune infiltration and could serve as an independent prognostic biomarker. Conclusively, our study emphasized the crucial role of NF-κB signaling pathway in GC immune microenviroment and provided several candidate genes that may participate in immune infiltration.
- Open Access
- 11 May 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (5) , 631
Preconditioned MSCs Alleviate Cerebral Ischemia-Reperfusion Injury in Rats by Improving the Neurological Function and the Inhibition of Apoptosis
Mesenchymal stem cells (MSCs) have great application prospects in the treatment of ischemic injury. However, their long-time cultivation before transplantation and poor survival after transplantation greatly limit the therapeutic effect and applications. This study aimed to investigate whether MSCs under the ischemic microenvironment could improve their survival and better alleviate cerebral ischemic injury. Firstly, we used ischemic brain tissue to culture MSCs and evaluated the functional changes of MSCs. Then a middle cerebral artery occlusion (MCAO) model was induced in rats, and the pretreated MSCs were injected via the tail vein. The adhesive removal test, rotarod test, modified neurological severity score, and pathological analyses were applied to assess the rats’ neurological function. Then the expression of neuron and apoptosis related markers was detected. The results indicated that ischemic brain tissue pretreated MSCs promoted the proliferation and the release of the growth factors of MSCs. Meanwhile, in MCAO model rats, transplantation of pretreated MSCs enhanced the neurogenesis, attenuated behavioral changes, reduced infarct size, and inhibited apoptosis. The expression of B-cell lymphoma-2 (Bcl-2), brain-derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), NF-L, and NeuN were increased, while BCL2-Associated X (Bax) and Caspase-3 decreased. Our results suggest that MSCs pretreatment with stroke brain tissue could be an effective strategy in treating cerebral ischemic injury.
- 11 May 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (5) , 631
Open AccessPreconditioned MSCs Alleviate Cerebral Ischemia-Reperfusion Injury in Rats by Improving the Neurological Function and the Inhibition of Apoptosis
Mesenchymal stem cells (MSCs) have great application prospects in the treatment of ischemic injury. However, their long-time cultivation before transplantation and poor survival after transplantation greatly limit the therapeutic effect and applications. This study aimed to investigate whether MSCs under the ischemic microenvironment could improve their survival and better alleviate cerebral ischemic injury. Firstly, we used ischemic brain tissue to culture MSCs and evaluated the functional changes of MSCs. Then a middle cerebral artery occlusion (MCAO) model was induced in rats, and the pretreated MSCs were injected via the tail vein. The adhesive removal test, rotarod test, modified neurological severity score, and pathological analyses were applied to assess the rats’ neurological function. Then the expression of neuron and apoptosis related markers was detected. The results indicated that ischemic brain tissue pretreated MSCs promoted the proliferation and the release of the growth factors of MSCs. Meanwhile, in MCAO model rats, transplantation of pretreated MSCs enhanced the neurogenesis, attenuated behavioral changes, reduced infarct size, and inhibited apoptosis. The expression of B-cell lymphoma-2 (Bcl-2), brain-derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), NF-L, and NeuN were increased, while BCL2-Associated X (Bax) and Caspase-3 decreased. Our results suggest that MSCs pretreatment with stroke brain tissue could be an effective strategy in treating cerebral ischemic injury.